Novel Non-opioid Post-surgical Pain Treatment in Females
Not yet recruiting
National Institutes of Health (NIH)
Phase 2
2021-10-30
This study aims to determine if treatment with Carbidopa/Levodopa and Naproxen in females
(biological sex) with acute pain after a bunionectomy or toe fusion (24hrs, 48hrs and 5 days)
will reduce pain when compared with females receiving Placebo and Naproxen.
Novel Non-opioid Post-surgical Pain Treatment in Females
Not yet recruiting
Northwestern Medical Group
Phase 2
2021-10-30
This study aims to determine if treatment with Carbidopa/Levodopa and Naproxen in females
(biological sex) with acute pain after a bunionectomy or toe fusion (24hrs, 48hrs and 5 days)
will reduce pain when compared with females receiving Placebo and Naproxen.
Novel Non-opioid Post-surgical Pain Treatment in Females
Not yet recruiting
Northwestern University
Phase 2
2021-10-30
This study aims to determine if treatment with Carbidopa/Levodopa and Naproxen in females
(biological sex) with acute pain after a bunionectomy or toe fusion (24hrs, 48hrs and 5 days)
will reduce pain when compared with females receiving Placebo and Naproxen.
BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's Disease
RECRUITING
Amneal Pharmaceuticals, LLC
PHASE4
2025-07-24
The purpose of this study is to evaluate the effect of IPX203 (Crexont) - the newest extended-release levodopa formulation - on the duration and quality of good on time, using a wearable device to monitor symptoms. 'Good on time' refers to a period (minutes to hours) when a patient experiences optimal symptom control due to effective medication and has better overall functioning without troublesome dyskinesias. The change in the duration and quality of on-time will be measured by a wearable device placed on your wrist called KinesiaU.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
